Providing digital solutions to educational/clinical fields. Announcing the release of the Digital Sight 1000 microscope camera

June 29, 2020 Nikon Corporation (Nikon) is pleased to announce the release of the Digital Sight 1000 microscope camera, providing digital solutions to educational/clinical fields. Product Information The microscope camera can obtain images during observation on the display in combination with a microscope. Digital solutions are currently in demand in many fields, with digital images... Read more

New Relate Software for Correlative Imaging with Atomic Force Microscopy and Electron Microscopy

June 10, 2020 (Santa Barbara, CA).  Oxford Instruments Asylum Research is pleased to announce the release of the new “Relate” software package for correlative imaging with Asylum Research AFMs, electron microscopes, and Oxford Instruments NanoAnalysis EDS and EBSD detectors. The Relate software makes it simple to correlate, visualise, and analyse the multitude of image data... Read more

Rigaku Allies With JEOL to Jointly Develop an Integrated MicroED Platform

✓    Rigaku and JEOL will unify their core technologies—Rigaku’s high-speed, high-sensitivity photon-counting detector (HPC) and state-of-the-art single crystal software, and JEOL’s  transmission electron microscope—to create an integrated MicroED platform providing one-step structure solutions with electron crystallography. ✓    The resulting MicroED platform, based on the synergistic collaboration of both companies, will provide a solution for the... Read more

Miltenyi Biotec launches world’s first fully automated light sheet microscope

The UltraMicroscope Blaze enables 3D imaging of large or multiple cleared samples across scalesBERGISCH GLADBACH, May 28, 2020 – Miltenyi Biotec today announces the UltraMicroscope Blaze. With cutting-edge optics, it is the world’s first and only fully automated light sheet microscope. The new instrument enables users to image an entire mouse or multiple samples at subcellular... Read more

Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia

Basel, 28 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoActemra plus the investigational antiviral remdesivir, versus placebo plus remdesivir in hospitalised patients with severe COVID-19 pneumonia, in collaboration with Gilead Sciences, Inc.  Read more

Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems and Software During Virtual ASMS Event

Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems and Software During Virtual ASMS Event Digital programs will enable scientists to broaden mass spectrometry-based research, from proteomics and biotherapeutics to clinical applications WALTHAM, Mass., May 27, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will provide online programming and... Read more

Roche’s Port Delivery System with ranibizumab shows positive phase III results in neovascular age-related macular degeneration

Basel, 27 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living with neovascular or “wet” age-related macular degeneration (nAMD). PDS is a permanent refillable eye implant, approximately the size of a grain of rice,... Read more

【Delayed】Consolidated Financial Statements for the Year Ended March 31, 2020 FY2020 (April 1, 2019 -March 31, 2020)[UNAUDITED]

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more